Astellas Gene Therapies clinical trials
Acquired by Astellas Pharma Inc, Jan 15, 2020 · source ↗
The registry lists 9 studies whose lead sponsor is Astellas Gene Therapies. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Before and after it joined Astellas Pharma Inc
- First submitted before Astellas Gene Therapies became part of Astellas Pharma Inc
- 4
- First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
- 5
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Astellas Gene Therapies9 studies
Something wrong with this grouping? Tell us on the Astellas Pharma Inc page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Astellas Pharma Inc studies →
- A Long-term Follow-up Study in Male Participants With X-linked Myotubular Myopathy Treated With ASP2957Not yet recruitingNCT07876804Phase 1/2
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
- A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle ConditionRecruitingNCT06581146
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
- Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need VentilatorsRecruitingNCT07052929Phase 1/2
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
- A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe DiseaseActive, not recruitingNCT06150820Not applicable
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
- A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)Active, not recruitingNCT03199469Phase 2/3
Sponsor listed in the registry: Astellas Gene Therapies · First submitted before Astellas Gene Therapies became part of Astellas Pharma Inc
- Gene Transfer Study in Patients With Late Onset Pompe DiseaseActive, not recruitingNCT04174105Phase 1/2
Sponsor listed in the registry: Astellas Gene Therapies · First submitted before Astellas Gene Therapies became part of Astellas Pharma Inc
- A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich AtaxiaWithdrawnNCT06483802Phase 1
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
- A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) SubjectsCompletedNCT02704273
Sponsor listed in the registry: Astellas Gene Therapies · First submitted before Astellas Gene Therapies became part of Astellas Pharma Inc
- A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)CompletedNCT02231697
Sponsor listed in the registry: Astellas Gene Therapies · First submitted before Astellas Gene Therapies became part of Astellas Pharma Inc